Das hepatozelluläres Karzinom der Kindheit wird durch somatische Mutationen im MET-Gen ausgelöst.
Yong KJ et. al. (2013) Oncofetal gene SALL4 in aggressive hepatocellular carcinoma.
Hopkins LJ et. al. (2013) Oncofetal gene SALL4 in aggressive hepatocellular carcinoma.
Suzuki E et. al. (2013) Oncofetal gene SALL4 in aggressive hepatocellular carcinoma.
Masuda S et. al. (2013) Oncofetal gene SALL4 in aggressive hepatocellular carcinoma.
Kishnani PS et. al. (2009) Chromosomal and genetic alterations in human hepatocellular adenomas associated with type Ia glycogen storage disease.
Napoli VM et. al. (1977) Hepatoblastoma in infant sister and brother.
Shen FM et. al. (1991) Complex segregation analysis of primary hepatocellular carcinoma in Chinese families: interaction of inherited susceptibility and hepatitis B viral infection.
Buetow KH et. al. (1989) Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma.
Pasquinelli C et. al. (1988) Rearrangement of a common cellular DNA domain on chromosome 4 in human primary liver tumors.
Henderson AS et. al. (1988) Identification of a chromosomal aberration associated with a hepatitis B DNA integration site in human cells.
Zhou YZ et. al. (1988) Structural analysis of a hepatitis B virus genome integrated into chromosome 17p of a human hepatocellular carcinoma.
Blanquet V et. al. (1988) Regional mapping to 4q32.1 by in situ hybridization of a DNA domain rearranged in human liver cancer.
Wang HP et. al. (1988) Deletions in human chromosome arms 11p and 13q in primary hepatocellular carcinomas.
Rogler CE et. al. (1985) Deletion in chromosome 11p associated with a hepatitis B integration site in hepatocellular carcinoma.
Fisher JH et. al. (1987) Sequences which flank an 11p deletion observed in an hepatocellular carcinoma map to 11p13.
Ito E et. al. (1987) Type 1a glycogen storage disease with hepatoblastoma in siblings.
Hagstrom RM et. al. (1968) Primary hepatocellular carcinoma in three male siblings.
Fraumeni JF et. al. (1969) Hepatoblastoma in infant sisters.
Denison EK et. al. (1971) Familial hepatoma with hepatitis-associated antigen.
Lynch HT et. al. (1984) Familial hepatocellular carcinoma in an endemic area of Thailand.
Chang MH et. al. (1984) Fraternal hepatocellular carcinoma in young children in two families.
McGlynn KA et. al. (1995) Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1.
Oda H et. al. (1996) Somatic mutations of the APC gene in sporadic hepatoblastomas.
Agarwal VR et. al. (1998) Molecular basis of severe gynecomastia associated with aromatase expression in a fibrolamellar hepatocellular carcinoma.
Schwienbacher C et. al. (2000) Gain of imprinting at chromosome 11p15: A pathogenetic mechanism identified in human hepatocarcinomas.
Taniguchi K et. al. (2002) Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas.
Thorgeirsson SS et. al. (2002) Molecular pathogenesis of human hepatocellular carcinoma.
Ye QH et. al. (2003) Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning.
Shin HD et. al. (2003) Interleukin 10 haplotype associated with increased risk of hepatocellular carcinoma.
KAPLAN L et. al. (1965) FRATERNAL PRIMARY HEPATOCELLULAR CARCINOMA IN THREE MALE, ADULT SIBLINGS.
Lee JW et. al. (2005) PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas.
Chiu CM et. al. (2007) Hepatitis B virus X protein enhances androgen receptor-responsive gene expression depending on androgen level.
Tanabe KK et. al. (2008) Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis.
Yoo BK et. al. (2009) Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression.
Hill-Baskin AE et. al. (2009) Diet-induced hepatocellular carcinoma in genetically predisposed mice.
Yoo BK et. al. (2009) Identification of genes conferring resistance to 5-fluorouracil.
Ji J et. al. (2009) MicroRNA expression, survival, and response to interferon in liver cancer.
Zhang H et. al. (2010) Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers.
Kumar V et. al. (2011) Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma.
Li M et. al. (2011) Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma.
Huang J et. al. (2012) Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma.
Honeyman JN et. al. (2014) Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma.